L A Barakat1,2, M Juthani-Mehta1,2, H Allore2, M Trentalange2, J Tate3, D Rimland4, M Pisani2,5, K M Akgün2,3,5, M B Goetz6, A A Butt7, M Rodriguez-Barradas8, M Duggal3, K Crothers9, A C Justice2,3, V J Quagliarello1,2. 1. Infectious Disease, Yale University School of Medicine, New Haven, CT, USA. 2. Internal Medicine, Yale University School of Medicine, New Haven, CT, USA. 3. Internal Medicine, VA Connecticut Healthcare System, West Haven, CT, USA. 4. Infectious Disease, VA Medical Center, Decatur, GA, USA. 5. Pulmonary Disease and Critical Care, Yale University School of Medicine, New Haven, CT, USA. 6. Infectious Disease, VA Greater Los Angles Healthcare System, Los Angelos, CA, USA. 7. Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA. 8. Infectious Diseases (MS 111G), Michael E. Debakey VA Medical Center, Houston, TX, USA. 9. Pulmonary Disease and Critical Care, University of Washington, Seattle, WA, USA.
Abstract
OBJECTIVES: Outcomes of community-acquired pneumonia (CAP) among HIV-infected older adults are unclear. METHODS: Associations between HIV infection and three CAP outcomes (30-day mortality, readmission within 30 days post-discharge, and hospital length of stay [LOS]) were examined in the Veterans Aging Cohort Study (VACS) of male Veterans, age ≥ 50 years, hospitalized for CAP from 10/1/2002 through 08/31/2010. Associations between the VACS Index and CAP outcomes were assessed in multivariable models. RESULTS: Among 117 557 Veterans (36 922 HIV-infected and 80 635 uninfected), 1203 met our eligibility criteria. The 30-day mortality rate was 5.3%, the mean LOS was 7.3 days, and 13.2% were readmitted within 30 days of discharge. In unadjusted analyses, there were no significant differences between HIV-infected and uninfected participants regarding the three CAP outcomes (P > 0.2). A higher VACS Index was associated with increased 30-day mortality, readmission, and LOS in both HIV-infected and uninfected groups. Generic organ system components of the VACS Index were associated with adverse CAP outcomes; HIV-specific components were not. Among HIV-infected participants, those not on antiretroviral therapy (ART) had a higher 30-day mortality (HR 2.94 [95% CI 1.51, 5.72]; P = 0.002) and a longer LOS (slope 2.69 days [95% CI 0.65, 4.73]; P = 0.008), after accounting for VACS Index. Readmission was not associated with ART use (OR 1.12 [95% CI 0.62, 2.00] P = 0.714). CONCLUSION: Among HIV-infected and uninfected older adults hospitalized for CAP, organ system components of the VACS Index were associated with adverse CAP outcomes. Among HIV-infected individuals, ART was associated with decreased 30-day mortality and LOS.
OBJECTIVES: Outcomes of community-acquired pneumonia (CAP) among HIV-infected older adults are unclear. METHODS: Associations between HIV infection and three CAP outcomes (30-day mortality, readmission within 30 days post-discharge, and hospital length of stay [LOS]) were examined in the Veterans Aging Cohort Study (VACS) of male Veterans, age ≥ 50 years, hospitalized for CAP from 10/1/2002 through 08/31/2010. Associations between the VACS Index and CAP outcomes were assessed in multivariable models. RESULTS: Among 117 557 Veterans (36 922 HIV-infected and 80 635 uninfected), 1203 met our eligibility criteria. The 30-day mortality rate was 5.3%, the mean LOS was 7.3 days, and 13.2% were readmitted within 30 days of discharge. In unadjusted analyses, there were no significant differences between HIV-infected and uninfected participants regarding the three CAP outcomes (P > 0.2). A higher VACS Index was associated with increased 30-day mortality, readmission, and LOS in both HIV-infected and uninfected groups. Generic organ system components of the VACS Index were associated with adverse CAP outcomes; HIV-specific components were not. Among HIV-infectedparticipants, those not on antiretroviral therapy (ART) had a higher 30-day mortality (HR 2.94 [95% CI 1.51, 5.72]; P = 0.002) and a longer LOS (slope 2.69 days [95% CI 0.65, 4.73]; P = 0.008), after accounting for VACS Index. Readmission was not associated with ART use (OR 1.12 [95% CI 0.62, 2.00] P = 0.714). CONCLUSION: Among HIV-infected and uninfected older adults hospitalized for CAP, organ system components of the VACS Index were associated with adverse CAP outcomes. Among HIV-infected individuals, ART was associated with decreased 30-day mortality and LOS.
Authors: L Baril; P Astagneau; J Nguyen; T Similowski; X Mengual; C Beigelman; E Caumes; C Katlama; F Bricaire Journal: Clin Infect Dis Date: 1998-04 Impact factor: 9.079
Authors: M Tumbarello; E Tacconelli; K de Gaetano; F Ardito; T Pirronti; R Cauda; L Ortona Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1998-05-01
Authors: Kristina Crothers; Bruce W Thompson; Kathryn Burkhardt; Alison Morris; Sonia C Flores; Philip T Diaz; Richard E Chaisson; Gregory D Kirk; William N Rom; Laurence Huang Journal: Proc Am Thorac Soc Date: 2011-06
Authors: Joseph L Goulet; Shawn L Fultz; David Rimland; Adeel Butt; Cynthia Gibert; Maria Rodriguez-Barradas; Kendall Bryant; Amy C Justice Journal: Clin Infect Dis Date: 2007-12-15 Impact factor: 9.079
Authors: Violet Awori; Gertrude Nakigozi; Alice Kisakye; James Batte; Aggrey Anok; Richard Mayanja; Noeline Nakasujja; Kevin R Robertson; Ronald H Gray; Maria J Wawer; Ned Sacktor; Deanna Saylor Journal: J Neurovirol Date: 2019-11-12 Impact factor: 2.643
Authors: Sebastien Kenmoe; Jean Joel Bigna; Abdou Fatawou Modiyingi; Marie S Ndangang; Paul Alain Ngoupo; Fredy Brice N Simo; Serges Tchatchouang; Elvis Temfack; Richard Njouom Journal: J Clin Virol Date: 2019-06-28 Impact factor: 3.168
Authors: Jerry S Zifodya; Meredith S Duncan; Kaku A So-Armah; Engi F Attia; Kathleen M Akgün; Maria C Rodriguez-Barradas; Vincent C Marconi; Matthew J Budoff; Roger J Bedimo; Charles W Alcorn; Guy W Soo Hoo; Adeel A Butt; Joon W Kim; Jason J Sico; Hilary A Tindle; Laurence Huang; Janet P Tate; Amy C Justice; Matthew S Freiberg; Kristina Crothers Journal: J Am Heart Assoc Date: 2020-11-23 Impact factor: 5.501